Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 689-734-6 | CAS number: 39903-01-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 28 Sep to 05 Oct 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study run to a method comparable with current guidelines and to GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- 2-amino-5-bromopyridin-3-ol
- EC Number:
- 689-734-6
- Cas Number:
- 39903-01-0
- Molecular formula:
- C5H5BrN2O
- IUPAC Name:
- 2-amino-5-bromopyridin-3-ol
- Details on test material:
- - Purity: 96.2% w/w
- Batch No.: CCS-952/STG-02/00109
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland, Sulzfeld, Germany.
- Age at study initiation: Approximately 9 weeks.
- Weight at study initiation: all animals within ± 20% of the sex mean.
- Fasting period before study:
- Housing: Group housing of 3 animals per sex in Macrolon cages with sterilized sawdust as bedding material and paper as cage-enrichment.
- Diet (e.g. ad libitum): Free access to pelleted rodent diet.
- Water (e.g. ad libitum): Free access to tap water.
- Acclimation period: At least 5 days before the start of treatment under laboratory conditions.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.0 ± 3.0ºC (actual range: 20.2 – 22.2ºC)
- Humidity (%): 40-70% (actual range: 43 - 76%)
- Air changes (per hr): Approximately 15 air changes per hour.
- Photoperiod (hrs dark / hrs light): 12 hours artificial fluorescent light and 12 hours darkness per day.
IN-LIFE DATES: From: 2010-09-28 To: 2010-10-05
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: polyethylene glycol 400
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
DIET PREPARATION
- Rate of preparation of diet (frequency):
- Mixing appropriate amounts with (Type of food):
- Storage temperature of food:
VEHICLE
- Justification for use and choice of vehicle (if other than water): Based on trial formulations performed at NOTOX and on information from the sponsor.
- Concentration in vehicle:
- Amount of vehicle (if gavage):
- Lot/batch no. (if required):
- Purity: - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 7 days
- Frequency of treatment:
- Once daily for up to 7 consecutive days, approximately the same time each day with a maximum of 6 hours difference between the earliest and latest dose.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
150, 300 and 600 mg/kg
Basis:
actual ingested
- No. of animals per sex per dose:
- 3 males and 3 females
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale:
- Rationale for animal assignment (if not random): Dose levels for this 7-day oral gavage study were selected to be 0, 150, 300 and 600 mg/kg, based on the results of the acute oral toxicity study (NOTOX project 494244) and on information from the sponsor.
- Rationale for selecting satellite groups:
- Post-exposure recovery period in satellite groups:
- Section schedule rationale (if not random):
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: No data
- Time schedule:
- Cage side observations checked in table [No.?] were included.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: At least once daily, detailed clinical observations were made in all animals. The time of onset,
degree and duration was recorded. All symptoms were recorded and graded according to fixed scales:
Maximum grade 1: grade 0 = absent, grade 1 = present
Maximum grade 3 or 4: grade 1 = slight, grade 2 = moderate, grade 3 = severe, grade 4 = very severe
BODY WEIGHT: Yes
- Time schedule for examinations: On Days 1, 4 and 7.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
Over Days 1-4 and 4-7.
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes / No / No data
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No data
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): Yes
- Time schedule for examinations: Subjective appraisal was maintained during the study, but no quantitative investigation introduced as no effect was suspected.
OPHTHALMOSCOPIC EXAMINATION: No data
- Time schedule for examinations:
- Dose groups that were examined:
HAEMATOLOGY: Yes / No / No data
- Time schedule for collection of blood:
- Anaesthetic used for blood collection: Yes (identity) / No / No data
- Animals fasted: Yes / No / No data
- How many animals:
- Parameters checked in table [No.?] were examined.
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: Blood samples were collected under anaesthesia using an isoflurane in nitrous oxide/oxygen combination immediately prior to scheduled post mortem examination, between 7.00 and 10.30 a.m. Animals were deprived of food overnight (for a maximum of 20 hours), but water was available. Blood samples were drawn from the retroorbital sinus and collected into tubes prepared with EDTA for haematological parameters (0.5 mL), with citrate for clotting tests (0.45 mL) and Li-heparin treated tubes for clinical biochemistry parameters (0.5 mL). An additional blood sample (0.25 mL) was collected into untreated tubes for determination of bile acids.
- Animals fasted: Yes / No / No data
- How many animals:
- Parameters checked in table [No.?] were examined.
URINALYSIS: No data
- Time schedule for collection of urine:
- Metabolism cages used for collection of urine: Yes / No / No data
- Animals fasted: Yes / No / No data
- Parameters checked in table [No.?] were examined.
NEUROBEHAVIOURAL EXAMINATION: No data
- Time schedule for examinations:
- Dose groups that were examined:
- Battery of functions tested: sensory activity / grip strength / motor activity / other:
OTHER: - Sacrifice and pathology:
- Necropsy:
Animals surviving to the end of the observation period were deeply anaesthetized using an isoflurane in nitrous oxide/oxygen combination and subsequently exsanguinated and subjected to a full post mortem examination. Samples of the tissues and organs were collected from all animals at necropsy and fixed in 10% buffered formalin.
Histotechnology:
All organ and tissue samples, as defined under Histopathology (following), were processed, embedded in paraffin wax and cut at a thickness of 2-4 micrometers and stained with haematoxylin and eosin.
Histopathology:
The following slides were examined by a pathologist: all tissues collected at the scheduled sacrifice from all group 1 and 4 animals; all gross lesions. All abnormalities were described and included in the report. An attempt was made to correlate gross observations with microscopic findings. - Other examinations:
- Mortality/Viability: At least twice daily.
Organ Weights: The organ weights (and terminal body weight) were recorded from the animals on the scheduled day of necropsy. - Statistics:
- None stated
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- effects observed, treatment-related
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- not specified
- Details on results:
- Mortality:
No mortality occurred during the study period.
Clinical Signs:
No clinical signs of toxicity were noted during the observation period.
All males at 300 and all males and females at 600 mg/kg showed salivation from Day 3 onwards. This slight degree of salivation is often noted in rats of this age and strain following oral gavage. Therefore salivation was not considered to be of toxicological relevance.
Body Weights:
Body weights of treated animals remained in the same range as controls over the study period.
Slightly reduced body weight gain was noted in males at 300 and 600 mg/kg at the end of the study period. The body weight gain remained within the expected range for these kinds of animals in this kind of study. This finding was therefore not regarded as toxicological relevant.
Food Consumption:
No toxicologically significant changes in food consumption before or after allowance for body weight were noted.
Haematology:
No toxicologically relevant changes occurred in haematological parameters of treated rats.
Clinical Biochemistry:
Higher total bilirubin, cholesterol and triglycerides and lower sodium level were noted in females at 600 mg/kg.
In males lower triglycerides were noted in a dose related response, most prominently at the highest dose level.
The higher glucose level and the lower cholesterol level in males at all dose levels were considered to be caused by the slightly lower glucose level and higher cholesterol level of the control group and therefore not considered to be of toxicological relevance.
Other changes in clinical biochemistry parameters were considered to be in the range expected for these rats and this kind of study.
Macroscopic Examination:
Necropsy did not reveal any toxicologically relevant alterations.
Other necropsy findings were considered to be of no toxicological significance since they occurred in the absence of a treatment-related distribution, and are occasionally seen among rats used in these types of studies. These findings included reduced size of testes and epididymides, nodules in epididymides, foci on thymus and fluid in the uterus.
Organ Weights:
Higher liver weight (absolute and relative) was noted in females at 600 mg/kg. In females at 300 mg/kg/day only a slightly higher liver weight (absolute and relative) was noted.
Other organ weights and organ to body weight ratios among the dose groups were similar to control levels.
Microscopic Examination:
There were no microscopic findings recorded which could be attributed to treatment with the test substance.
All microscopic findings were within the range of background pathology encountered in Wistar rats of this age and strain and occurred at similar incidences and severity in both control and treated rats.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- > 600 mg/kg bw/day (actual dose received)
- Based on:
- act. ingr.
- Sex:
- male/female
- Basis for effect level:
- other: No toxicologically adverse effects at highest dose level tested
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- From the results presented in this report it was concluded that the test substance has no toxic potential when administered to rats by daily oral gavage for a period of up to 7 consecutive days up to 600 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)